SI0804234T1 - Vaccine adjuvant - Google Patents

Vaccine adjuvant

Info

Publication number
SI0804234T1
SI0804234T1 SI9530216T SI9530216T SI0804234T1 SI 0804234 T1 SI0804234 T1 SI 0804234T1 SI 9530216 T SI9530216 T SI 9530216T SI 9530216 T SI9530216 T SI 9530216T SI 0804234 T1 SI0804234 T1 SI 0804234T1
Authority
SI
Slovenia
Prior art keywords
adjuvants
repeating units
vaccine adjuvant
constitutive repeating
constitutive
Prior art date
Application number
SI9530216T
Other languages
English (en)
Slovenian (sl)
Inventor
Luuk Hilgers
Michel Strebelle
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Publication of SI0804234T1 publication Critical patent/SI0804234T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Devices For Use In Laboratory Experiments (AREA)
SI9530216T 1994-12-27 1995-12-21 Vaccine adjuvant SI0804234T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9401173A BE1008977A5 (fr) 1994-12-27 1994-12-27 Adjuvants pour vaccins.
EP95942006A EP0804234B1 (fr) 1994-12-27 1995-12-21 Adjuvant pour vaccins
PCT/BE1995/000118 WO1996020007A1 (fr) 1994-12-27 1995-12-21 Adjuvants pour vaccins

Publications (1)

Publication Number Publication Date
SI0804234T1 true SI0804234T1 (en) 1999-08-31

Family

ID=3888559

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530216T SI0804234T1 (en) 1994-12-27 1995-12-21 Vaccine adjuvant

Country Status (15)

Country Link
US (1) US6340464B1 (da)
EP (1) EP0804234B1 (da)
JP (1) JP3817655B2 (da)
CN (1) CN1087177C (da)
AT (1) ATE180676T1 (da)
AU (1) AU713660B2 (da)
BE (1) BE1008977A5 (da)
BR (1) BR9510286A (da)
CA (1) CA2208860C (da)
DE (1) DE69510089T2 (da)
DK (1) DK0804234T3 (da)
ES (1) ES2131879T3 (da)
GR (1) GR3031103T3 (da)
SI (1) SI0804234T1 (da)
WO (1) WO1996020007A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
JP2018020962A (ja) * 2014-12-08 2018-02-08 エヌエーアイ株式会社 新規アジュバント
AU2017286727B2 (en) * 2016-06-17 2024-02-08 Boehringer Ingelheim Animal Health USA Inc. Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
CN110404064B (zh) * 2018-04-27 2023-06-16 洛阳赛威生物科技有限公司 一种禽用佐剂组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE161050C (da) *
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3790655A (en) * 1971-03-02 1974-02-05 E B & A C Whiting Co Method for commingling and orienting colored sets of thermoplastic filaments
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US5047238A (en) * 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
EP0273512B1 (en) * 1986-12-19 1991-02-27 Duphar International Research B.V Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
US5565209A (en) * 1987-03-17 1996-10-15 Akzo Nobel N.V. Adjuvant mixture
ZA881694B (en) * 1987-03-17 1988-09-06 Akzo N.V. Adjuvant mixture
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
JP3723231B2 (ja) * 1991-12-23 2005-12-07 ディミナコ アクチェンゲゼルシャフト アジュバント
CN1043041C (zh) * 1994-04-22 1999-04-21 住友化学工业株式会社 含有杂环基的醚类衍生物和以其作为活性成分的杀虫剂

Also Published As

Publication number Publication date
ES2131879T3 (es) 1999-08-01
BR9510286A (pt) 1997-11-11
DE69510089D1 (en) 1999-07-08
CA2208860A1 (en) 1996-07-04
MX9704823A (es) 1998-06-30
ATE180676T1 (de) 1999-06-15
EP0804234A1 (fr) 1997-11-05
JPH11502191A (ja) 1999-02-23
CA2208860C (en) 2009-03-17
GR3031103T3 (en) 1999-12-31
DE69510089T2 (de) 1999-09-23
US6340464B1 (en) 2002-01-22
AU713660B2 (en) 1999-12-09
CN1171053A (zh) 1998-01-21
CN1087177C (zh) 2002-07-10
WO1996020007A1 (fr) 1996-07-04
AU4324796A (en) 1996-07-19
BE1008977A5 (fr) 1996-10-01
JP3817655B2 (ja) 2006-09-06
EP0804234B1 (fr) 1999-06-02
DK0804234T3 (da) 1999-11-15

Similar Documents

Publication Publication Date Title
DE69428795D1 (de) Phosphazene und polyelektrolyte als immunadjuvantien
EP0269926A3 (en) Lens usable in the ultraviolet
EP0657478A3 (en) Process for the preparation of water-soluble polymer dispersions.
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
EP0647428A3 (en) Interactive image-guided surgery system.
FI935804A0 (fi) Foerfarande foer papperstillverkning under anvaendande av tvaerbundna katjoniska/amfoteriska staerkelser
AU4324896A (en) Vaccine adjuvants
EP0718364A4 (en) AQUEOUS FLUOROPOLYMER EMULSION AND METHOD FOR THE PRODUCTION THEREOF
EP0640096A4 (en) UNIVERSAL CORONAVIRUS VACCINE.
AUPM612494A0 (en) Treatment or prevention of helicobacter infection
AU3853495A (en) Immunogenic compositions
SI0804234T1 (en) Vaccine adjuvant
CA2182274A1 (en) Antigenic preparation for treatment or prevention of helicobacter infection
AU4015493A (en) Process for preparing polysuccinimides from aspartic acid
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
CA2216410A1 (en) Improved inactivated vaccines
AU5297999A (en) Use of a composition
HUT77018A (hu) Eljárás terpolimerek előállítására
CA2111083A1 (en) Novel peptides, their preparation and use
CA2037709A1 (en) Use of zinc calcium hydroxide, lecithin and pao as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type
AU8085691A (en) Activation of polysaccharide hydrolase
MX9505078A (es) Procedimientos para la preparacion de halogenodifluoroacetatos de alquilo.
GR3019525T3 (en) Neuraminidase and galactose oxidase as vaccine adjuvant
ZA83640B (en) Ozone inactivated organisms as vaccines
AU561683B2 (en) Combined influenza, diphtheria, tetanus vaccine

Legal Events

Date Code Title Description
SP73 Change of data on owner

Owner name: PFIZER AG; CH

Effective date: 20101209

SP73 Change of data on owner

Owner name: ZOETIS SCHWEIZ GMBH; CH

Effective date: 20130801